Prognia
Drug Database
🇺🇸US · FDA ApprovedNone (Tentative Approval)ANDA216775-001

ACALABRUTINIB

Manufacturer: ALEMBIC PHARMS LTD

FDA Approval: 18/01/2023

Route: ORAL · CAPSULE

Active Ingredients

ACALABRUTINIB 100MG

AI Drug & Interaction Analysis

Free account required

Ask Prognia AI about ACALABRUTINIB — check interactions with your patient's full medication list, get dosing recommendations with renal/hepatic adjustments, and explore guideline-cited evidence.

Medical disclaimer: This drug information is intended for qualified healthcare professionals only. Always verify with the official FDA prescribing information before clinical use.